Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 60687-405

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 60687-405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.5 mg/ 3 mg Per 3 mL Ipratropium Bromide And Albuterol Sulfate Inhalation Solution Carton (Ahp Ipra Alb 0 5 3mg 30ct Carton Flat Image)

Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution 0.5 mg/3 mg per 3 mL by American Health Packaging. The product is supplied as 30 sterile unit-dose vials of 3 mL each, intended for oral inhalation administration. The label includes dosage strength, NDC 60687-405-83, manufacturer logo, and storage instructions.*

FDA Label Image

Ipratropium Bromide And Albuterol Sulfate Solution Foil Label (Rpfp0223 Ahp Ipra Alb 0 5mg 3mg 1ct Foil Image 01)

Label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution 0.5 mg/3 mg per 3 mL, a respiratory inhalation solution by American Health Packaging. The label provides concentration, instructions for oral inhalation use only, storage conditions, and package details for a sterile unit-dose vial containing 3 mL.*

FDA Label Image

Figure 1 (Image 01)

An instructional diagram showing an inhalation device with a canister being inserted or attached, likely illustrating the assembly or preparation step for a respiratory inhalation solution.*

FDA Label Image

Figure 2 (Image 02)

Illustration showing how to attach a vial or ampule to a respiratory inhalation device, likely for administration of Ipratropium Bromide and Albuterol Sulfate inhalation solution. The image depicts a hand holding the device and aligning the vial for connection.*

FDA Label Image

Figures 3 And 4 (Image 03)

This illustration diagram contains two figures depicting the use of a respiratory inhalation device for Ipratropium Bromide and Albuterol Sulfate solution. Figure 3 shows a person inhaling through a mouthpiece attached to the inhalation device. Figure 4 shows a person inhaling through a face mask connected to the device. Both images demonstrate proper administration technique using different interfaces.*

FDA Label Image

Chemical Structure (Ipratropium 01)

Chemical structure diagram of Ipratropium Bromide and Albuterol Sulfate highlighting the molecular arrangement, including functional groups and sulfate ions, associated with these active ingredients in the inhalation solution form.*

FDA Label Image

Chemical Structure (Ipratropium 02)

Chemical structure diagram of Ipratropium Bromide, an active ingredient in Ipratropium Bromide and Albuterol Sulfate inhalation solution. The diagram displays the molecular arrangement including a tropane ring, an ester linkage, and a bromide hydrate moiety.*

FDA Label Image

Figure (Ipratropium 03)

A line graph illustrating lung volume in liters over time (hours after dosing) for Albuterol, Ipratropium, and their combination (Ipratropium Bromide and Albuterol Sulfate). The graph shows changes in lung volume from 0 to 8 hours post-dosing, comparing the effects of each treatment.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.